Targeting EIF4F complex in non-small cell lung cancer cells

Non-small cell lung cancer (NSCLC) accounts for about 85–90% of lung cancer cases, which represents the leading cause of cancer-related death in the world. The majority of lung cancer patients doesn't respond well to conventional chemo-/radio-therapeutic regimens and have a poor prognosis. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Lu, Lin, Zhen, Cao, Yueyu, Chen, Yihan, Xu, Zengguang, Qin, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589694/
https://www.ncbi.nlm.nih.gov/pubmed/28903455
http://dx.doi.org/10.18632/oncotarget.18413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589694/
https://www.ncbi.nlm.nih.gov/pubmed/28903455
http://dx.doi.org/10.18632/oncotarget.18413

Ejemplares similares